Published News » Pharmaceutical

Shareholder objection scuppered deal, says American company

American medical research equipment and services company Charles River Laboratories International Inc on Friday abandoned its $1.6 billion takeover of WuXi PharmaTech (Cayman) Inc, citing opposition from its shareholders to the deal.

New York-listed WuXi PharmaTech is a pharmaceutical and biotechnology research and developme
Drugmaker Merck Sharp & Dohme (MSD) started work on a new manufacturing site in Hangzhou on Monday as part of its expansion plans in China.

The 70,000 sq m manufacturing site in Hangzhou Economic and Technological Area has been set up with a total investment of 1.1 billion yuan and is one of the largest pharmaceutical packaging projects undertaken by Merck in recent times.

The unit is expec




Copyright © My China B2B - Cloud Edition  |  Powered by My China B2B  |  Qiao LAB - Shanghai High-Tech & Business Incubator